Phase-Pure α-FAPbI3 Perovskite Solar Cells via Activating Lead-Iodine Frameworks

© 2023 Wiley‐VCH GmbH.

Détails bibliographiques
Publié dans:Advanced materials (Deerfield Beach, Fla.). - 1998. - 36(2024), 13 vom: 31. März, Seite e2309171
Auteur principal: Niu, Tingting (Auteur)
Autres auteurs: Chao, Lingfeng, Xia, Yingdong, Wang, Kaiyu, Ran, Xueqin, Huang, Xiao, Chen, Changshun, Wang, Jinpei, Li, Deli, Su, Zhenhuang, Hu, Zhelu, Gao, Xingyu, Zhang, Jing, Chen, Yonghua
Format: Article en ligne
Langue:English
Publié: 2024
Accès à la collection:Advanced materials (Deerfield Beach, Fla.)
Sujets:Journal Article Pb─I frameworks chemical interaction phase transition phase‐pure α‐FAPbI3
Description
Résumé:© 2023 Wiley‐VCH GmbH.
Narrow bandgap cubic formamidine perovskite (α-FAPbI3) is widely studied for its potential to achieve record‑breaking efficiency. However, its high preparation difficulty caused by lattice instability is criticized. A popular strategy for stabilizing the α-FAPbI3 lattice is to replace intrinsic FA+ or I- with smaller ions of MA+, Cs+, Rb+, and Br-, whereas this generally leads to broadened optical bandgap and phase separation. Studies show that ions substitution-free phase-pure α-FAPbI3 can achieve intrinsic phase stability. However, the challenging preparation of high-quality films has hindered its further development. Here, a facile synthesis of high-quality MA+, Cs+, Rb+, and Br--free phase-pure α-FAPbI3 perovskite film by a new solution modification strategy is reported. This enables the activation of lead-iodine (Pb─I) frameworks by forming the coated Pb⋯O network, thus simultaneously promoting spontaneous homogeneous nucleation and rapid phase transition from δ to α phase. As a result, the efficient and stable phase-pure α-FAPbI3 PSC is obtained through a one-step method without antisolvent treatment, with a record efficiency of 23.15% and excellent long-term operating stability for 500 h under continuous light stress
Description:Date Revised 28.03.2024
published: Print-Electronic
Citation Status PubMed-not-MEDLINE
ISSN:1521-4095
DOI:10.1002/adma.202309171